Quantinno Capital Management LP Makes New $436,000 Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT)
Quantinno Capital Management LP acquired a new position in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 9,656 shares of the biopharmaceutical company’s stock, valued at approximately $436,000. Other hedge funds and other institutional investors also recently […]
